Market Insights Health Hospitals Inpatient Care

Neoplasm Treatment - ASEAN

ASEAN

The Neoplasm Treatment market in ASEAN is expected to witness a significant increase in revenue.
In 2024, the projected revenue is estimated to reach US$7.45bn.
This demonstrates the potential growth and opportunities within the market segment.
Looking ahead, the market is predicted to exhibit a compound annual growth rate (CAGR 2024-2029) of 7.31%.
This steady growth is anticipated to result in a market volume of US$10.60bn by 2029.
When compared globally, it is noteworthy that in the United States is projected to generate the highest revenue in the Neoplasm Treatment market.
In 2024, in the United States is expected to contribute a substantial amount, amounting to US$90.56bn.
This showcases the dominance and significance of the United States in the global market landscape.
In the ASEAN region, Thailand has emerged as a leader in neoplasm treatment, with a strong emphasis on innovative therapies and a growing number of specialized treatment centers.

Key regions: India, Japan, United States, United Kingdom, Germany

Market

Region

Region comparison

Currency

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on revenue received by hospitals from public or private sources, allocated to the country where the money is spent, including VAT if applicable.

Modeling approach / Market size:

Market sizes are determined by a bottom-up approach, based on a specific rationale for each market market. Next, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, public health spend, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.